These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

194 related items for PubMed ID: 18511196

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Parthenolide prevents the expression of cocaine-induced withdrawal behavior in planarians.
    Rowlands AL, Pagán OR.
    Eur J Pharmacol; 2008 Mar 31; 583(1):170-2. PubMed ID: 18275955
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Nociceptin attenuates methamphetamine abstinence-induced withdrawal-like behavior in planarians.
    Rawls SM, Baron S, Ding Z, Roth C, Zaveri N, Raffa RB.
    Neuropeptides; 2008 Jun 31; 42(3):229-37. PubMed ID: 18479746
    [Abstract] [Full Text] [Related]

  • 9. First evidence that drugs of abuse produce behavioral sensitization and cross sensitization in planarians.
    Rawls SM, Patil T, Yuvasheva E, Raffa RB.
    Behav Pharmacol; 2010 Jul 31; 21(4):301-13. PubMed ID: 20512030
    [Abstract] [Full Text] [Related]

  • 10. Reversal of cocaine-induced planarian behavior by parthenolide and related sesquiterpene lactones.
    Pagán OR, Rowlands AL, Azam M, Urban KR, Bidja AH, Roy DM, Feeney RB, Afshari LK.
    Pharmacol Biochem Behav; 2008 Apr 31; 89(2):160-70. PubMed ID: 18222535
    [Abstract] [Full Text] [Related]

  • 11. Caffeine dependence in rats: effects of exposure duration and concentration.
    Dingle RN, Dreumont-Boudreau SE, Lolordo VM.
    Physiol Behav; 2008 Sep 03; 95(1-2):252-7. PubMed ID: 18598710
    [Abstract] [Full Text] [Related]

  • 12. Reversal of cocaine withdrawal-induced anxiety by ondansetron, buspirone and propranolol.
    de Oliveira Citó Mdo C, da Silva FC, Silva MI, Moura BA, Macêdo DS, Woods DJ, Fonteles MM, de Vasconcelos SM, de Sousa FC.
    Behav Brain Res; 2012 May 16; 231(1):116-23. PubMed ID: 22374255
    [Abstract] [Full Text] [Related]

  • 13. Haloperidol (but not ziprasidone) withdrawal enhances cocaine-induced locomotor activation and conditioned place preference in mice.
    Fukushiro DF, Alvarez Jdo N, Tatsu JA, de Castro JP, Chinen CC, Frussa-Filho R.
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 May 09; 31(4):867-72. PubMed ID: 17368685
    [Abstract] [Full Text] [Related]

  • 14. Subadditive withdrawal from cocaine/kappa-opioid agonist combinations in Planaria.
    Raffa RB, Stagliano GW, Tallarida RJ.
    Brain Res; 2006 Oct 09; 1114(1):31-5. PubMed ID: 16914122
    [Abstract] [Full Text] [Related]

  • 15. Caffeine withdrawal syndrome in social interaction test in mice: effects of the NMDA receptor channel blockers, memantine and neramexane.
    Sukhotina IA, Zvartau EE, Danysz W, Bespalov AY.
    Behav Pharmacol; 2004 May 09; 15(3):207-14. PubMed ID: 15187578
    [Abstract] [Full Text] [Related]

  • 16. Development of a home cage locomotor tracking system capable of detecting the stimulant and sedative properties of drugs in rats.
    Dunne F, O'Halloran A, Kelly JP.
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Oct 01; 31(7):1456-63. PubMed ID: 17706334
    [Abstract] [Full Text] [Related]

  • 17. Prolonged daily exposure to i.v. cocaine results in tolerance to its stimulant effects.
    Ben-Shahar O, Moscarello JM, Jacob B, Roarty MP, Ettenberg A.
    Pharmacol Biochem Behav; 2005 Oct 01; 82(2):411-6. PubMed ID: 16253318
    [Abstract] [Full Text] [Related]

  • 18. Caffeine withdrawal: a parametric analysis of caffeine dosing conditions.
    Evans SM, Griffiths RR.
    J Pharmacol Exp Ther; 1999 Apr 01; 289(1):285-94. PubMed ID: 10087016
    [Abstract] [Full Text] [Related]

  • 19. Chronic benzylpiperazine (BZP) exposure produces behavioral sensitization and cross-sensitization to methamphetamine (MA).
    Brennan K, Johnstone A, Fitzmaurice P, Lea R, Schenk S.
    Drug Alcohol Depend; 2007 May 11; 88(2-3):204-13. PubMed ID: 17125936
    [Abstract] [Full Text] [Related]

  • 20. Anxiety-like behaviors following chronic ethanol exposure.
    Kliethermes CL.
    Neurosci Biobehav Rev; 2005 Jan 11; 28(8):837-50. PubMed ID: 15642625
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.